Psi Advisors, LLC Exact Sciences Corp Transaction History
Psi Advisors, LLC
- $314 Million
- Q2 2024
A detailed history of Psi Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Psi Advisors, LLC holds 50 shares of EXAS stock, worth $3,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$3,399
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.24 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.12 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.01 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$820 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$558 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...